Mayo Clinic researchers have developed aptamers — small DNA molecules with a precise three-dimensional shape — that selectively mark senescent ("zombie") cells in living tissue, a feat that has been difficult to achieve until then. [1] The project began as an idea between two graduate students and grew into a cross-laboratory collaboration that identified aptamers that bind to the unique surface proteins of senescent cells. [1] Aptamers have allowed researchers to distinguish senescent cells by surface markers without relying reliably on intrinsic markers or telomere shortening. [1] This method provides a new way to visualize and target cells associated with aging and chronic diseases. [1] According to the article, this is a significant step in the study of senescence, as senescent cells have so far been "elusive" in living tissue. [1] Thus, the main finding of the study is that aptamers can selectively bind surface proteins of senescent cells, which opens up possibilities for their detection and potential targeted interventions. [1]